Latest-1

For front page news

Oxular Sponsors ISU 2022

Oxular is thrilled to sponsor ISU 2022 in Utrecht, The Netherlands, and introduce the Oxulumis® suprachoroidal microcatheter to leading uveitis specialists. Together with Marc D. de Smet, we will host a series of skill transfer labs and provide hands-on instruction for routine suprachoroidal drug administration using Oxulumis®. We look forward to seeing you all there.

Oxular presents at Eyecelerator

Our CEO, Tom Cavanagh, presented an overview of Oxular’s retinal therapeutics platform at Eyecelerator, during AAO 2021. It was a pleasure to share this update, with a specific focus on OXU-001, Oxular’s lead program investigating a long-lasting, suprachoroidally administered treatment for DME. You can read Tom’s presentation below. Play Previous Next

Scroll to Top